Explore the US Deprescribing Research Network (USDeN)
Describing deprescribing: How do GPs discuss deprescribing topics with their patients, and how in-depth do they go?
Thompson W, Jarbøl D, Nielsen JB, Haastrup P, Pedersen LB. GP preferences for discussing statin deprescribing: a discrete choice experiment. Fam Pract. 2022;39(1):26-31. doi:10.1093/fampra/cmab075 Although
Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMIZE Pragmatic Cluster Randomized Trial
IMPACT Collaboratory Grand Rounds Co-Hosted with USDeN
Presenter(s):
Elizabeth Bayliss, MD MSPH &
Cynthia Boyd, MD, MPH
May 19, 2022
12:00-1:00 PM Eastern
9:00–10:00 AM Pacific
USDeN Call for Pilot Studies Preparatory to Large Clinical Trials
Complementary and Integrative Health Interventions to Support Deprescribing of Benzodiazepine Receptor Agonists in Older Adults The US Deprescribing Research Network (USDeN) will soon be seeking
New Cohort of Junior Investigators Selected!
We are thrilled to announce our 2022-2023 cohort of Junior Investigator Intensive Awardees. The Junior Investigator Intensive program provides dedicated supports and research learning opportunities
Annual Network Meeting
US Deprescribing Research Network Annual Meeting
Wednesday, May 11, 2022
